Skip to main content

Table 3 Outcomes: sternal wound complication incidence and grade and overall survival in the entire study population

From: Skeletonisation contributing to a reduction of sternal wound complications: a retrospective study in OPCAB patients

Variable

Non-skeletonized (n = 1487)

Skeletonized (n = 413)

Odds ratio (95% CI)

P

SWC incidence

190 (12.78)

39 (9.44)

0.71 (0.50;1.02)

0.067

   

0.74 (0.51;1.07)a

0.114a

SWC incidence (grade 1 excluded)

116 (7.80)

20 (4.84)

0.60 (0.37;0.98)

0.041

   

0.635 (0.387;1.042)

0.072a

SWC grade

  

0.70 (0.49;1.01)

0.054

   

0.73 (0.50;1.05)a

0.091a

SWC grade (grade 1 excluded)

  

0.59 (0.36;0.97)

0.036

   

0.62 (0.38;1.02)

0.062a

1

74 (4.98)

19 (4.60)

  

2

27 (1.82)

10 (2.42)

  

3

63 (4.24)

7 (1.69)

  

4

26 (1.75)

3 (0.73)

  

Overall survival (%, 95 CI)

  

1.00 (0.52;1.91)

1

   

0.92 (0.48;1.75)a

0.791a

1 month

97.99 (97.08;98.62)

98.81 (96.82;99.56)

  

6 months

95.67 (94.36;96.68)

96.61 (92.39;98.50)

  

12 months

94.42 (92.94;95.60)

92.25 (82.32;96.71)

  
  1. SWC sternal wound complication, CI confidence interval
  2. aCorrected for diabetes mellitus and BIMA
  3. Values are presented as mean ± SD or n (%) if not otherwise specified
  4. P < 0.05 was considered significant